NIH awards contracts for COVID-19 rapid point-of-care tests
The National Institutes of Health last week announced as part of its Rapid Acceleration of Diagnostics initiative $129.3 million in contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.
Among the tests are some that use RT-PCR and a device that can give results in 15 minutes and strips that can be read without specialized equipment, similar to pregnancy tests.
In addition, NIH said it is adding five additional laboratories to expand the network of coverage and potentially manage tens of thousands of additional tests daily.
Related News Articles
Headline
The International Hospital Federation has extended the nomination deadline to May 3 for its 2024 awards honoring excellence in hospitals and health care…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
During its Annual Membership Meeting April 14 in Washington, D.C., the AHA honored 2024 Board Chair Joanne Conroy, M.D., president and CEO of Dartmouth Health…
Headline
On April 15 at the AHA Annual Membership Meeting in Washington, D.C., AHA will present Nancy Howell Agee, CEO of Carilion Clinic, and Brian Gragnolati,…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…